J&J to cut 3000 jobs in medical devices unit


Healthcare giant Johnson & Johnson plans to eliminate around 3000 jobs from its medical devices operations. The cuts represent approximately 2.5% of the company’s global workforce, or 5% of the medical devices segment.

The redundancies will come from orthopaedic, surgical and cardiovascular device areas, while consumer medical devices, vision and diabetes businesses are unaffected. The company says it is restructuring to focus on areas in which it can be the number one or two player. The changes are intended to streamline its operations and ‘accelerate the pace of innovation’, while saving the company a projected $800 million (£560 million) a year.


Related Content

Medical devices consolidation continues

4 February 2016 Business

news image

Abbott to buy Alere for $5.8bn to augment its point-of-care diagnostics business

Business roundup

27 January 2012 Business

news image

Industry news, February 2012

Most Commented

WHO clarifies glyphosate risks

23 May 2016 Business

news image

UN and WHO panel conclude the herbicide glyphosate is ‘unlikely’ to cause cancer at realistic exposure levels

Large HIV vaccine trial to launch in South Africa

24 May 2016 News and Analysis

news image

US funding agency will enlist 5400 people for HIV vaccine study in South Africa in November